{
    "xml": "<topic id=\"PHP4364\" outputclass=\"drug\" rev=\"1.18\" type=\"drug\" namespace=\"/drugs/dexamethasone\" basename=\"dexamethasone\" title=\"DEXAMETHASONE\">\n<title>DEXAMETHASONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_490\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/dexamethasone\">Dexamethasone</xref>\n</p>\n<data name=\"vtmid\">7561000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP40397\" outputclass=\"indicationsAndDose\" rev=\"1.109\" parent=\"/drugs/dexamethasone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5&#8211;10&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local treatment of inflammation (short term)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially to the eye using eye drop</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 4&#8211;6 times a day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply every 30&#8211;60&#8239;minutes until controlled, then (to the eye) reduced to 4&#8211;6 times a day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short term local treatment of inflammation (severe conditions)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye using eye drop</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply every 30&#8211;60&#8239;minutes until controlled, reduce frequency when control achieved.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Macular oedema following either branch retinal vein occlusion or central retinal vein occlusion (specialist use only)</p>\n<p outputclass=\"therapeuticIndication\">Visual impairment due to diabetic macular oedema in adults who are pseudophakic, or who are insufficiently responsive to, or unsuitable for non-corticosteroid therapy (specialist use only)</p>\n<p outputclass=\"therapeuticIndication\">For the treatment of inflammation of the posterior segment of the eye presenting as non-infectious uveitis (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravitreal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>700&#8239;micrograms, to be administered into the affected eye, concurrent administration to both eyes not recommended. For further information on pre-treatment, administration and repeat dosing, consult product literature.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild croup</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>150&#8239;micrograms/kg for 1 dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8239;micrograms/kg for 1 dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe croup (or mild croup that might cause complications)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Initially 150&#8239;micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg after 12&#8239;hours if required.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 150&#8239;micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg after 12&#8239;hours if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Diagnosis of Cushing&#8217;s disease</p>\n<p outputclass=\"therapeuticIndication\">Congenital adrenal hyperplasia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5&#8211;10&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.4&#8211;20&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Overnight dexamethasone supression test</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg for 1 dose, to be given at night.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of bacterial meningitis (starting before or with first dose of antibacterial)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8.3&#8239;mg every 6&#8239;hours for 4 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Symptom control of anorexia (in palliative care)</p>\n</sectiondiv>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8211;4&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Obstruction due to tumour (dysphagia in palliative care)</p>\n</sectiondiv>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bronchospasm or partial obstruction (dyspnoea in palliative care)</p>\n</sectiondiv>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>4&#8211;8&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nausea and vomiting (adjunct in palliative care)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8&#8211;16&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Headaches due to raised intracranial pressure (in palliative care)</p>\n</sectiondiv>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>16&#8239;mg daily for 4&#8211;5 days, then reduced to 4&#8211;6&#8239;mg daily, reduce dose if possible. To be given before 6pm to reduce the risk of insomnia.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Pain due to nerve compression (in palliative care)</p>\n</sectiondiv>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cerebral oedema associated with malignancy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.5&#8211;10&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cerebral oedema (with dexamethasone as sodium phosphate 3.8&#8239;mg/mL injection)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 8&#8211;16&#8239;mg, then (by intramuscular injection or by intravenous injection) 5&#8239;mg every 6&#8239;hours until adequate response achieved then taper-off gradually.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cerebral oedema associated with malignancy (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 8.3&#8239;mg, then (by intramuscular injection) 3.3&#8239;mg every 6&#8239;hours as required for 2&#8211;4 days, subsequently, reduce dose gradually and stop over 5&#8211;7 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local inflammation of joints (with dexamethasone as sodium phosphate 3.8&#8239;mg/mL injection)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intra-articular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.3&#8211;3&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days according to response.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local inflammation of joints (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intra-articular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.33&#8211;3.3&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local inflammation of soft tissues (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By local infiltration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1.7&#8211;5&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38993\" outputclass=\"unlicensedUse\" rev=\"1.18\" parent=\"/drugs/dexamethasone\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Consult product literature; not licensed for use in bacterial meningitis.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph> in children</p>\n<p>\n<i>Maxidex</i>\n<tm tmtype=\"reg\"/> not licensed for use in children under 2 years.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph> in children</p>\n<p>\n<i>Dropodex</i>\n<tm tmtype=\"reg\"/> not licensed for use in children.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40861\" outputclass=\"contraindications\" rev=\"1.30\" parent=\"/drugs/dexamethasone\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"contraindication\">avoid alone in the presence of untreated infection (combine with suitable anti-infective)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravitreal use</p>\n<p>\n<ph outputclass=\"contraindication\">active ocular herpes simplex</ph> (in adults); <ph outputclass=\"contraindication\">active or suspected ocular infection</ph> (in adults); <ph outputclass=\"contraindication\">active or suspected periocular infection</ph> (in adults); <ph outputclass=\"contraindication\">rupture of the posterior lens capsule in patients with aphakia, iris or transscleral fixated intra-ocular lens or anterior chamber intra-ocular lens</ph> (in adults); <ph outputclass=\"contraindication\">uncontrolled advanced glaucoma</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41035\" outputclass=\"cautions\" rev=\"1.48\" parent=\"/drugs/dexamethasone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"caution\">avoid prolonged use</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravitreal use</p>\n<p>\n<ph outputclass=\"caution\">history of ocular viral infection (including herpes simplex)</ph> (in adults); <ph outputclass=\"caution\">posterior capsule tear or iris defect (risk of implant migration into the anterior chamber which may cause corneal oedema and, in persistent severe cases, the need for corneal transplantation)</ph> (in adults); <ph outputclass=\"caution\">retinal vein occlusion with significant retinal ischaemia</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40229\" outputclass=\"interactions\" rev=\"1.15\" parent=\"/drugs/dexamethasone\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\n<p>Caution with concomitant administration of anticoagulant or antiplatelet drugs&#8212;increased risk of haemorrhagic events.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39493\" outputclass=\"sideEffects\" rev=\"1.30\" parent=\"/drugs/dexamethasone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravitreal use</p>\n<p>\n<ph outputclass=\"sideEffect\">eyelid pruritus</ph> (in adults); <ph outputclass=\"sideEffect\">glaucoma</ph> (in adults); <ph outputclass=\"sideEffect\">migraine</ph> (in adults); <ph outputclass=\"sideEffect\">necrotising retinitis</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"sideEffect\">local sensitivity reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by eye</p>\n<p>\n<ph outputclass=\"sideEffect\">adrenal suppression following prolonged use in neonates</ph> (in neonates); <ph outputclass=\"sideEffect\">corneal thinning</ph>; <ph outputclass=\"sideEffect\">scleral thinning</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">perineal irritation may follow intravenous administration of the phosphate ester</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravitreal use</p>\n<p>\n<ph outputclass=\"sideEffect\">blepharitis</ph> (in adults); <ph outputclass=\"sideEffect\">cataract</ph> (in adults); <ph outputclass=\"sideEffect\">headache</ph> (in adults); <ph outputclass=\"sideEffect\">ocular hypertension</ph> (in adults); <ph outputclass=\"sideEffect\">raised intra-ocular pressure</ph> (in adults); <ph outputclass=\"sideEffect\">secondary ocular infection</ph> (in adults); <ph outputclass=\"sideEffect\">visual disturbance</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40144\" outputclass=\"pregnancy\" parent=\"/drugs/dexamethasone\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\n<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Dexamethasone readily crosses the placenta.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41132\" outputclass=\"breastFeeding\" parent=\"/drugs/dexamethasone\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\n<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38841\" outputclass=\"monitoringRequirements\" parent=\"/drugs/dexamethasone\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\n<p>Monitor intra-ocular pressure and for signs of ocular infection. In patients with posterior capsule tear or iris defect monitor for implant migration to allow for; early diagnosis and management.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP41243\" outputclass=\"directionsForAdministration\" rev=\"1.15\" parent=\"/drugs/dexamethasone\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>For administration <i>by mouth</i> tablets may be dispersed in water or injection solution given by mouth.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i> dilute with Glucose 5% or Sodium Chloride 0.9%; give over 15&#8211;20 minutes.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Dexamethasone</i>, Hospira) give continuously <i>or</i> intermittently <i>or via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59026\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.29\" parent=\"/drugs/dexamethasone\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dexamethasone 3.8&#8239;mg/mL Injection has replaced Dexamethasone 4&#8239;mg/mL Injection.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph>\n</p>\n<p>Although multi-dose Dexamethasone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40005\" outputclass=\"patientAndCarerAdvice\" rev=\"1.22\" parent=\"/drugs/dexamethasone\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Dexamethasone for croup</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/dexamethasone-croup-0\">www.medicinesforchildren.org.uk/dexamethasone-croup-0</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\r\n<p>Patient counselling is advised for dexamethasone tablet, oral solution and injection (steroid card).</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP38436\" outputclass=\"nationalFunding\" rev=\"1.17\" parent=\"/drugs/dexamethasone\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA229</p>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\r\n<p outputclass=\"title\">Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (July 2011)</p>\r\n<p>Dexamethasone intravitreal implant is recommended as an option for the treatment of macular oedema following central retinal vein occlusion.</p>\r\n<p>Dexamethasone intravitreal implant is also recommended as an option for the treatment of macular oedema following branch retinal vein occlusion when:</p>\r\n<ul>\r\n<li>treatment with laser photocoagulation has not been beneficial, <i>or</i>\r\n</li>\r\n<li>treatment with laser photocoagulation is not considered suitable because of the extent of macular haemorrhage.</li>\r\n</ul>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA229\">www.nice.org.uk/TA229</xref>\n</sectiondiv>\n</sectiondiv>\r\n<sectiondiv outputclass=\"smcDecisions\">\r\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\r\n<sectiondiv outputclass=\"smcDecision\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p>\r\n<p>The <i>Scottish Medicines Consortium</i> has advised (May 2012) that dexamethasone intravitreal implant (<i>Ozurdex</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for the treatment of adults with macular oedema (i) following central retinal vein occlusion, and (ii) with branch retinal vein occlusion who are not clinically suitable for laser treatment, including patients with dense macular haemorrhage, or patients who have received and failed on previous laser treatment.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4364-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/dexamethasone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: eye drops, oral suspension, oral solution, capsule</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75668\" title=\"Tablet\" namespace=\"/drugs/dexamethasone/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75717\" title=\"Oral solution\" namespace=\"/drugs/dexamethasone/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75704\" title=\"Solution for injection\" namespace=\"/drugs/dexamethasone/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75710\" title=\"Eye drops\" namespace=\"/drugs/dexamethasone/eye-drops\">Eye drops</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75696\" title=\"Implant\" namespace=\"/drugs/dexamethasone/implant\">Implant</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88007\" namespace=\"/drugs/dexamethasone-with-tobramycin\" title=\"DEXAMETHASONE WITH TOBRAMYCIN\" count=\"1\" rel=\"backlink\">DEXAMETHASONE WITH TOBRAMYCIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP92555\" namespace=\"/drugs/dexamethasone-with-framycetin-sulfate-and-gramicidin\" title=\"DEXAMETHASONE WITH FRAMYCETIN SULFATE AND GRAMICIDIN\" count=\"1\" rel=\"backlink\">DEXAMETHASONE WITH FRAMYCETIN SULFATE AND GRAMICIDIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP92557\" namespace=\"/drugs/dexamethasone-with-glacial-acetic-acid-and-neomycin-sulfate\" title=\"DEXAMETHASONE WITH GLACIAL ACETIC ACID AND NEOMYCIN SULFATE\" count=\"1\" rel=\"backlink\">DEXAMETHASONE WITH GLACIAL ACETIC ACID AND NEOMYCIN SULFATE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP98628\" namespace=\"/drugs/dexamethasone-with-hypromellose-neomycin-and-polymyxin-b-sulphate\" title=\"DEXAMETHASONE WITH HYPROMELLOSE, NEOMYCIN AND POLYMYXIN B SULPHATE\" count=\"1\" rel=\"backlink\">DEXAMETHASONE WITH HYPROMELLOSE, NEOMYCIN AND POLYMYXIN B SULPHATE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"6\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78118\" namespace=\"/treatment-summaries/croup-medical-emergency\" title=\"Croup, medical emergency\" count=\"1\" rel=\"backlink\">Croup, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78221\" namespace=\"/treatment-summaries/nausea-and-labyrinth-disorders\" title=\"Nausea and labyrinth disorders\" count=\"3\" rel=\"backlink\">Nausea and labyrinth disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78288\" namespace=\"/treatment-summaries/glucocorticoid-therapy\" title=\"Glucocorticoid therapy\" count=\"2\" rel=\"backlink\">Glucocorticoid therapy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78293\" namespace=\"/treatment-summaries/corticosteroids-general-use\" title=\"Corticosteroids, general use\" count=\"5\" rel=\"backlink\">Corticosteroids, general use</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78488\" namespace=\"/treatment-summaries/soft-tissue-disorders\" title=\"Soft-tissue disorders\" count=\"1\" rel=\"backlink\">Soft-tissue disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78513\" namespace=\"/treatment-summaries/eye-allergy-and-inflammation\" title=\"Eye, allergy and inflammation\" count=\"1\" rel=\"backlink\">Eye, allergy and inflammation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78519\" namespace=\"/treatment-summaries/croup\" title=\"Croup\" count=\"3\" rel=\"backlink\">Croup</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78537\" namespace=\"/treatment-summaries/cytotoxic-drugs\" title=\"Cytotoxic drugs\" count=\"4\" rel=\"backlink\">Cytotoxic drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78553\" namespace=\"/treatment-summaries/central-nervous-system-infections-bacterial\" title=\"Central nervous system infections, bacterial\" count=\"5\" rel=\"backlink\">Central nervous system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78557\" namespace=\"/treatment-summaries/eye\" title=\"Eye\" count=\"1\" rel=\"backlink\">Eye</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_490\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/dexamethasone\" title=\"Dexamethasone\" count=\"1\" rel=\"link\">Dexamethasone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75668\" namespace=\"/drugs/dexamethasone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75717\" namespace=\"/drugs/dexamethasone/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75704\" namespace=\"/drugs/dexamethasone/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75710\" namespace=\"/drugs/dexamethasone/eye-drops\" title=\"Eye drops\" count=\"1\" rel=\"link\">Eye drops</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75696\" namespace=\"/drugs/dexamethasone/implant\" title=\"Implant\" count=\"1\" rel=\"link\">Implant</xref>\n</links>\n</topic>",
    "id": "PHP4364",
    "outputclass": "drug",
    "rev": "1.18",
    "type": "drug",
    "namespace": "/drugs/dexamethasone",
    "basename": "dexamethasone",
    "title": "DEXAMETHASONE",
    "interactants": [
        {
            "id": "bnf_int_490",
            "label": "Dexamethasone"
        }
    ],
    "vtmid": "7561000",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders",
                        "html": "Suppression of inflammatory and allergic disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "0.5&#8211;10 mg daily.",
                        "html": "<p>0.5&#8211;10&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Local treatment of inflammation (short term)",
                        "html": "Local treatment of inflammation (short term)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially to the eye using eye drop"
                    ],
                    "textContent": "Initially to the eye using eye drop",
                    "html": "Initially to the eye using eye drop"
                },
                "child": [
                    {
                        "textContent": "Apply 4&#8211;6 times a day.",
                        "html": "<p>Apply 4&#8211;6 times a day.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply every 30&#8211;60 minutes until controlled, then (to the eye) reduced to 4&#8211;6 times a day.",
                        "html": "<p>Apply every 30&#8211;60&#8239;minutes until controlled, then (to the eye) reduced to 4&#8211;6 times a day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Short term local treatment of inflammation (severe conditions)",
                        "html": "Short term local treatment of inflammation (severe conditions)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye using eye drop"
                    ],
                    "textContent": "To the eye using eye drop",
                    "html": "To the eye using eye drop"
                },
                "child": [
                    {
                        "textContent": "Apply every 30&#8211;60 minutes until controlled, reduce frequency when control achieved.",
                        "html": "<p>Apply every 30&#8211;60&#8239;minutes until controlled, reduce frequency when control achieved.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Macular oedema following either branch retinal vein occlusion or central retinal vein occlusion (specialist use only)",
                        "html": "Macular oedema following either branch retinal vein occlusion or central retinal vein occlusion (specialist use only)"
                    },
                    {
                        "textContent": "Visual impairment due to diabetic macular oedema in adults who are pseudophakic, or who are insufficiently responsive to, or unsuitable for non-corticosteroid therapy (specialist use only)",
                        "html": "Visual impairment due to diabetic macular oedema in adults who are pseudophakic, or who are insufficiently responsive to, or unsuitable for non-corticosteroid therapy (specialist use only)"
                    },
                    {
                        "textContent": "For the treatment of inflammation of the posterior segment of the eye presenting as non-infectious uveitis (specialist use only)",
                        "html": "For the treatment of inflammation of the posterior segment of the eye presenting as non-infectious uveitis (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravitreal injection"
                    ],
                    "textContent": "By intravitreal injection",
                    "html": "By intravitreal injection"
                },
                "adult": [
                    {
                        "textContent": "700 micrograms, to be administered into the affected eye, concurrent administration to both eyes not recommended. For further information on pre-treatment, administration and repeat dosing, consult product literature.",
                        "html": "<p>700&#8239;micrograms, to be administered into the affected eye, concurrent administration to both eyes not recommended. For further information on pre-treatment, administration and repeat dosing, consult product literature.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild croup",
                        "html": "Mild croup"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "150 micrograms/kg for 1 dose.",
                        "html": "<p>150&#8239;micrograms/kg for 1 dose.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "150 micrograms/kg for 1 dose.",
                        "html": "<p>150&#8239;micrograms/kg for 1 dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe croup (or mild croup that might cause complications)",
                        "html": "Severe croup (or mild croup that might cause complications)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth"
                    ],
                    "textContent": "Initially by mouth",
                    "html": "Initially by mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 150 micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150 micrograms/kg, then (by mouth or by intravenous injection) 150 micrograms/kg after 12 hours if required.",
                        "html": "<p>Initially 150&#8239;micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg after 12&#8239;hours if required.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 150 micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150 micrograms/kg, then (by mouth or by intravenous injection) 150 micrograms/kg after 12 hours if required.",
                        "html": "<p>Initially 150&#8239;micrograms/kg for 1 dose, to be given before transfer to hospital, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg, then (by mouth or by intravenous injection) 150&#8239;micrograms/kg after 12&#8239;hours if required.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Diagnosis of Cushing&#8217;s disease",
                        "html": "Diagnosis of Cushing&#8217;s disease"
                    },
                    {
                        "textContent": "Congenital adrenal hyperplasia",
                        "html": "Congenital adrenal hyperplasia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by slow intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "0.5&#8211;10 mg daily.",
                        "html": "<p>0.5&#8211;10&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "0.4&#8211;20 mg.",
                        "html": "<p>0.4&#8211;20&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Overnight dexamethasone supression test",
                        "html": "Overnight dexamethasone supression test"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 mg for 1 dose, to be given at night.",
                        "html": "<p>1&#8239;mg for 1 dose, to be given at night.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of bacterial meningitis (starting before or with first dose of antibacterial)",
                        "html": "Adjunctive treatment of bacterial meningitis (starting before or with first dose of antibacterial)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "8.3 mg every 6 hours for 4 days.",
                        "html": "<p>8.3&#8239;mg every 6&#8239;hours for 4 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Symptom control of anorexia (in palliative care)",
                        "html": "Symptom control of anorexia (in palliative care)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "2&#8211;4 mg daily.",
                        "html": "<p>2&#8211;4&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Obstruction due to tumour (dysphagia in palliative care)",
                        "html": "Obstruction due to tumour (dysphagia in palliative care)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "8 mg daily.",
                        "html": "<p>8&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Bronchospasm or partial obstruction (dyspnoea in palliative care)",
                        "html": "Bronchospasm or partial obstruction (dyspnoea in palliative care)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "4&#8211;8 mg daily.",
                        "html": "<p>4&#8211;8&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nausea and vomiting (adjunct in palliative care)",
                        "html": "Nausea and vomiting (adjunct in palliative care)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "8&#8211;16 mg daily.",
                        "html": "<p>8&#8211;16&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Headaches due to raised intracranial pressure (in palliative care)",
                        "html": "Headaches due to raised intracranial pressure (in palliative care)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "16 mg daily for 4&#8211;5 days, then reduced to 4&#8211;6 mg daily, reduce dose if possible. To be given before 6pm to reduce the risk of insomnia.",
                        "html": "<p>16&#8239;mg daily for 4&#8211;5 days, then reduced to 4&#8211;6&#8239;mg daily, reduce dose if possible. To be given before 6pm to reduce the risk of insomnia.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Pain due to nerve compression (in palliative care)",
                        "html": "Pain due to nerve compression (in palliative care)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "8 mg daily.",
                        "html": "<p>8&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Cerebral oedema associated with malignancy",
                        "html": "Cerebral oedema associated with malignancy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "0.5&#8211;10 mg daily.",
                        "html": "<p>0.5&#8211;10&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Cerebral oedema (with dexamethasone as sodium phosphate 3.8 mg/mL injection)",
                        "html": "Cerebral oedema (with dexamethasone as sodium phosphate 3.8&#8239;mg/mL injection)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 8&#8211;16 mg, then (by intramuscular injection or by intravenous injection) 5 mg every 6 hours until adequate response achieved then taper-off gradually.",
                        "html": "<p>Initially 8&#8211;16&#8239;mg, then (by intramuscular injection or by intravenous injection) 5&#8239;mg every 6&#8239;hours until adequate response achieved then taper-off gradually.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Cerebral oedema associated with malignancy (with dexamethasone as sodium phosphate 3.3 mg/mL injection)",
                        "html": "Cerebral oedema associated with malignancy (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 8.3 mg, then (by intramuscular injection) 3.3 mg every 6 hours as required for 2&#8211;4 days, subsequently, reduce dose gradually and stop over 5&#8211;7 days.",
                        "html": "<p>Initially 8.3&#8239;mg, then (by intramuscular injection) 3.3&#8239;mg every 6&#8239;hours as required for 2&#8211;4 days, subsequently, reduce dose gradually and stop over 5&#8211;7 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Local inflammation of joints (with dexamethasone as sodium phosphate 3.8 mg/mL injection)",
                        "html": "Local inflammation of joints (with dexamethasone as sodium phosphate 3.8&#8239;mg/mL injection)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intra-articular injection"
                    ],
                    "textContent": "By intra-articular injection",
                    "html": "By intra-articular injection"
                },
                "adult": [
                    {
                        "textContent": "0.3&#8211;3 mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days according to response.",
                        "html": "<p>0.3&#8211;3&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days according to response.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Local inflammation of joints (with dexamethasone as sodium phosphate 3.3 mg/mL injection)",
                        "html": "Local inflammation of joints (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intra-articular injection"
                    ],
                    "textContent": "By intra-articular injection",
                    "html": "By intra-articular injection"
                },
                "adult": [
                    {
                        "textContent": "0.33&#8211;3.3 mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.",
                        "html": "<p>0.33&#8211;3.3&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Local inflammation of soft tissues (with dexamethasone as sodium phosphate 3.3 mg/mL injection)",
                        "html": "Local inflammation of soft tissues (with dexamethasone as sodium phosphate 3.3&#8239;mg/mL injection)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "local infiltration"
                    ],
                    "textContent": "By local infiltration",
                    "html": "By local infiltration"
                },
                "adult": [
                    {
                        "textContent": "1.7&#8211;5 mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.",
                        "html": "<p>1.7&#8211;5&#8239;mg, dose given according to size, where appropriate may be repeated at intervals of 3&#8211;21 days.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Consult product literature; not licensed for use in bacterial meningitis.",
                "html": "<p>Consult product literature; not licensed for use in bacterial meningitis.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by eye in children",
                    "html": "When used by <ph outputclass=\"route\">eye</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Maxidex not licensed for use in children under 2 years.",
                "html": "<p>\n<i>Maxidex</i>\n<tm tmtype=\"reg\"/> not licensed for use in children under 2 years.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by eye in children",
                    "html": "When used by <ph outputclass=\"route\">eye</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Dropodex not licensed for use in children.",
                "html": "<p>\n<i>Dropodex</i>\n<tm tmtype=\"reg\"/> not licensed for use in children.</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid alone in the presence of untreated infection (combine with suitable anti-infective)",
                "html": "avoid alone in the presence of untreated infection (combine with suitable anti-infective)",
                "specificity": {
                    "textContent": "When used by ear",
                    "html": "When used by ear",
                    "routes": [
                        "ear"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "active ocular herpes simplex in adults",
                "html": "active ocular herpes simplex in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "active or suspected ocular infection in adults",
                "html": "active or suspected ocular infection in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "active or suspected periocular infection in adults",
                "html": "active or suspected periocular infection in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "rupture of the posterior lens capsule in patients with aphakia, iris or transscleral fixated intra-ocular lens or anterior chamber intra-ocular lens in adults",
                "html": "rupture of the posterior lens capsule in patients with aphakia, iris or transscleral fixated intra-ocular lens or anterior chamber intra-ocular lens in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "uncontrolled advanced glaucoma in adults",
                "html": "uncontrolled advanced glaucoma in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid prolonged use",
                "html": "avoid prolonged use",
                "specificity": {
                    "textContent": "When used by ear",
                    "html": "When used by ear",
                    "routes": [
                        "ear"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "history of ocular viral infection (including herpes simplex) in adults",
                "html": "history of ocular viral infection (including herpes simplex) in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "posterior capsule tear or iris defect (risk of implant migration into the anterior chamber which may cause corneal oedema and, in persistent severe cases, the need for corneal transplantation) in adults",
                "html": "posterior capsule tear or iris defect (risk of implant migration into the anterior chamber which may cause corneal oedema and, in persistent severe cases, the need for corneal transplantation) in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "retinal vein occlusion with significant retinal ischaemia in adults",
                "html": "retinal vein occlusion with significant retinal ischaemia in adults",
                "specificity": {
                    "textContent": "With intravitreal use",
                    "html": "With intravitreal use",
                    "routes": [
                        "intravitreal"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "specificity": {
                    "textContent": "With intravitreal use in adults",
                    "html": "With <ph outputclass=\"route\">intravitreal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravitreal"
                    ]
                },
                "textContent": "Caution with concomitant administration of anticoagulant or antiplatelet drugs&#8212;increased risk of haemorrhagic events.",
                "html": "<p>Caution with concomitant administration of anticoagulant or antiplatelet drugs&#8212;increased risk of haemorrhagic events.</p>"
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "uncommon": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "eyelid pruritus in adults",
                        "html": "eyelid pruritus in adults",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "glaucoma in adults",
                        "html": "glaucoma in adults",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "migraine in adults",
                        "html": "migraine in adults",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "necrotising retinitis in adults",
                        "html": "necrotising retinitis in adults",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "local sensitivity reactions",
                        "html": "local sensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by ear",
                            "html": "When used by ear",
                            "routes": [
                                "ear"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "adrenal suppression following prolonged use in neonates in neonates",
                        "html": "adrenal suppression following prolonged use in neonates in neonates",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ],
                            "patientType": "neonates"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "corneal thinning",
                        "html": "corneal thinning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "scleral thinning",
                        "html": "scleral thinning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "perineal irritation may follow intravenous administration of the phosphate ester",
                        "html": "perineal irritation may follow intravenous administration of the phosphate ester",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "blepharitis in adults",
                        "html": "blepharitis in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "cataract in adults",
                        "html": "cataract in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "headache in adults",
                        "html": "headache in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "ocular hypertension in adults",
                        "html": "ocular hypertension in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "raised intra-ocular pressure in adults",
                        "html": "raised intra-ocular pressure in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "secondary ocular infection in adults",
                        "html": "secondary ocular infection in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "visual disturbance in adults",
                        "html": "visual disturbance in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravitreal use",
                            "html": "With intravitreal use",
                            "routes": [
                                "intravitreal"
                            ],
                            "patientType": "adults"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intravitreal use in adults",
                    "html": "With <ph outputclass=\"route\">intravitreal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravitreal"
                    ]
                },
                "textContent": "Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.</p>"
            },
            {
                "type": "generalInformation",
                "textContent": "Dexamethasone readily crosses the placenta.",
                "html": "<p>Dexamethasone readily crosses the placenta.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intravitreal use in adults",
                    "html": "With <ph outputclass=\"route\">intravitreal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravitreal"
                    ]
                },
                "textContent": "Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid unless potential benefit outweighs risk&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With intravitreal use in adults",
                    "html": "With <ph outputclass=\"route\">intravitreal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravitreal"
                    ]
                },
                "textContent": "Monitor intra-ocular pressure and for signs of ocular infection. In patients with posterior capsule tear or iris defect monitor for implant migration to allow for; early diagnosis and management.",
                "html": "<p>Monitor intra-ocular pressure and for signs of ocular infection. In patients with posterior capsule tear or iris defect monitor for implant migration to allow for; early diagnosis and management.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For administration by mouth tablets may be dispersed in water or injection solution given by mouth.",
                "html": "<p>For administration <i>by mouth</i> tablets may be dispersed in water or injection solution given by mouth.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion dilute with Glucose 5% or Sodium Chloride 0.9%; give over 15&#8211;20 minutes.",
                "html": "<p>For <i>intravenous infusion</i> dilute with Glucose 5% or Sodium Chloride 0.9%; give over 15&#8211;20 minutes.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Dexamethasone, Hospira) give continuously or intermittently or via drip tubing in Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Dexamethasone</i>, Hospira) give continuously <i>or</i> intermittently <i>or via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dexamethasone 3.8 mg/mL Injection has replaced Dexamethasone 4 mg/mL Injection.",
                "html": "<p>Dexamethasone 3.8&#8239;mg/mL Injection has replaced Dexamethasone 4&#8239;mg/mL Injection.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "When used by eye",
                    "html": "When used by <ph outputclass=\"route\">eye</ph>",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Although multi-dose Dexamethasone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.",
                "html": "<p>Although multi-dose Dexamethasone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/dexamethasone-croup-0",
                        "label": "www.medicinesforchildren.org.uk/dexamethasone-croup-0"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Dexamethasone for croup",
                "textContent": "www.medicinesforchildren.org.uk/dexamethasone-croup-0",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/dexamethasone-croup-0\">www.medicinesforchildren.org.uk/dexamethasone-croup-0</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Patient counselling is advised for dexamethasone tablet, oral solution and injection (steroid card).",
                "html": "<p>Patient counselling is advised for dexamethasone tablet, oral solution and injection (steroid card).</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA229",
                        "label": "www.nice.org.uk/TA229"
                    }
                ],
                "fundingIdentifier": "NICE TA229",
                "textContent": "With intravitreal use in adults Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (July 2011) Dexamethasone intravitreal implant is recommended as an option for the treatment of macular oedema following central retinal vein occlusion. Dexamethasone intravitreal implant is also recommended as an option for the treatment of macular oedema following branch retinal vein occlusion when: treatment with laser photocoagulation has not been beneficial, or treatment with laser photocoagulation is not considered suitable because of the extent of macular haemorrhage.\n\nwww.nice.org.uk/TA229",
                "html": "<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravitreal</ph> use in adults</p> <p outputclass=\"title\">Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (July 2011)</p> <p>Dexamethasone intravitreal implant is recommended as an option for the treatment of macular oedema following central retinal vein occlusion.</p> <p>Dexamethasone intravitreal implant is also recommended as an option for the treatment of macular oedema following branch retinal vein occlusion when:</p> <ul> <li>treatment with laser photocoagulation has not been beneficial, <i>or</i> </li> <li>treatment with laser photocoagulation is not considered suitable because of the extent of macular haemorrhage.</li> </ul><xref format=\"html\" href=\"http://www.nice.org.uk/TA229\">www.nice.org.uk/TA229</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "eye drops",
                "oral suspension",
                "oral solution",
                "capsule"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75668",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75717",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75704",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75710",
                "label": "Eye drops",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75696",
                "label": "Implant",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88007",
                "label": "DEXAMETHASONE WITH TOBRAMYCIN",
                "type": "drug"
            },
            {
                "id": "PHP92555",
                "label": "DEXAMETHASONE WITH FRAMYCETIN SULFATE AND GRAMICIDIN",
                "type": "drug"
            },
            {
                "id": "PHP92557",
                "label": "DEXAMETHASONE WITH GLACIAL ACETIC ACID AND NEOMYCIN SULFATE",
                "type": "drug"
            },
            {
                "id": "PHP98628",
                "label": "DEXAMETHASONE WITH HYPROMELLOSE, NEOMYCIN AND POLYMYXIN B SULPHATE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78118",
                "label": "Croup, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78221",
                "label": "Nausea and labyrinth disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78288",
                "label": "Glucocorticoid therapy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78293",
                "label": "Corticosteroids, general use",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78488",
                "label": "Soft-tissue disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78513",
                "label": "Eye, allergy and inflammation",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78519",
                "label": "Croup",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78537",
                "label": "Cytotoxic drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78553",
                "label": "Central nervous system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78557",
                "label": "Eye",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_490",
                "label": "Dexamethasone",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75668",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75717",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75704",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75710",
                "label": "Eye drops",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75696",
                "label": "Implant",
                "type": "medicinalForm"
            }
        ]
    }
}